Paul D. Kessler Insider Trading $VXRT Vaxart, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Paul D. Kessler.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Paul D. Kessler. Paul D. Kessler is SVP Clinical, Med. & Reg.; CMO in Aviragen Therapeutics, Inc. ($NABI).

Paul D. Kessler in Vaxart, Inc.

Trading Symbol: VXRT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Paul D. Kessler: SVP Clinical, Med. & Reg.; CMO
Holdings: 110,295 shares
Current Value: $125,736
Latest Transaction: May 18 2011
$VXRT Market Capitalization: $43.28M
$VXRT Previous Close: $1.14

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Paul D. Kessler in Vaxart, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 18 2011	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.48	4,876	26,712	110,295	115.2 K to 110.3 K (-4.23 %)
May 18 2011	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.53	7,500	41,447	115,171	122.7 K to 115.2 K (-6.11 %)
Apr 05 2011	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Option Exercise	A	5.81	90,000	522,900	90,000
Apr 05 2011	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.76	8,596	49,479	122,671	131.3 K to 122.7 K (-6.55 %)
Apr 05 2011	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Grant	A	0.00	36,000	0	131,267	95.3 K to 131.3 K (+37.79 %)
Mar 31 2011	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Option Exercise	A	5.86	1,000	5,860	1,000
Jan 07 2011	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.65	2,985	16,869	95,267	98.3 K to 95.3 K (-3.04 %)
May 19 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.76	200	1,152	98,252	98.5 K to 98.3 K (-0.20 %)
May 19 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.75	600	3,450	98,452	99.1 K to 98.5 K (-0.61 %)
May 19 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.74	1,003	5,757	99,052	100.1 K to 99.1 K (-1.00 %)
May 19 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.73	1,400	8,022	100,055	101.5 K to 100.1 K (-1.38 %)
May 19 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.73	100	573	101,455	101.6 K to 101.5 K (-0.10 %)
May 19 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.72	1,900	10,868	101,555	103.5 K to 101.6 K (-1.84 %)
May 19 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.72	100	572	103,455	103.6 K to 103.5 K (-0.10 %)
May 19 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.71	3,592	20,510	103,555	107.1 K to 103.6 K (-3.35 %)
May 19 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.71	700	3,994	107,147	107.8 K to 107.1 K (-0.65 %)
May 19 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.70	3,205	18,269	107,847	111.1 K to 107.8 K (-2.89 %)
May 19 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.70	1,000	5,695	111,052	112.1 K to 111.1 K (-0.89 %)
May 19 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.69	850	4,837	112,052	112.9 K to 112.1 K (-0.75 %)
May 19 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.69	50	284	112,902	113 K to 112.9 K (-0.04 %)
May 19 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.68	300	1,704	112,952	113.3 K to 113 K (-0.26 %)
Apr 07 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.39	600	3,234	113,252	113.9 K to 113.3 K (-0.53 %)
Apr 07 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.38	600	3,228	113,852	114.5 K to 113.9 K (-0.52 %)
Apr 07 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.37	500	2,685	114,452	115 K to 114.5 K (-0.43 %)
Apr 07 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.36	200	1,072	114,952	115.2 K to 115 K (-0.17 %)
Apr 07 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.34	700	3,738	115,152	115.9 K to 115.2 K (-0.60 %)
Apr 07 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.32	1,520	8,086	115,852	117.4 K to 115.9 K (-1.30 %)
Apr 07 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.31	928	4,928	117,372	118.3 K to 117.4 K (-0.78 %)
Apr 07 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.30	200	1,060	118,300	118.5 K to 118.3 K (-0.17 %)
Apr 05 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Option Exercise	A	5.49	90,000	494,100	90,000
Apr 05 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Grant	A	0.00	36,000	0	118,500	82.5 K to 118.5 K (+43.64 %)
Nov 25 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.00	602	3,011	82,500	83.1 K to 82.5 K (-0.72 %)
Nov 23 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	4.89	5,502	26,905	83,102	88.6 K to 83.1 K (-6.21 %)
Nov 23 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	4.90	7,136	34,966	88,604	95.7 K to 88.6 K (-7.45 %)
Nov 23 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	4.91	2,000	9,820	95,740	97.7 K to 95.7 K (-2.05 %)
Nov 23 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	4.92	1,000	4,920	97,740	98.7 K to 97.7 K (-1.01 %)
Nov 23 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	4.90	2,500	12,250	98,740	101.2 K to 98.7 K (-2.47 %)
Apr 03 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Option Exercise	A	3.78	90,000	340,200	90,000
Apr 03 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Grant	A	0.00	30,000	0	101,240	71.2 K to 101.2 K (+42.11 %)

Page: 1